Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8787670 | Journal of Thoracic Oncology | 2018 | 23 Pages |
Abstract
Our findings suggested that the density of PD-L1-positive CD4-positive CD25-positive Tregs in the tumor microenvironment can serve as a diagnostic factor to supplement PD-L1 expression in tumor cells and predict the response to PD-1/PD-L1 blockade immunotherapy in NSCLC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Si-Pei PhD, Ri-Qiang MD, Hai-Yan MD, Wen-Jun MD, PhD, Zhong-Yi MD, Shu-Mei MS, Wei-Bang BS, Lan-Ying MD, Hui-Wen MS, Qi PhD, Zhi BS, Li-Xu PhD, Jian BS, Jin-Ji MD, Wen-Zhao MD, Xu-Chao MD, PhD, Yi-Long MD,